BeStock  
Markets › Compare › PBH vs AMLX

PBH vs AMLX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PBH · Prestige Consumer Healthcare$49.63 ▲ 0.06%
AMLX · Amylyx Pharmaceuticals$26.02 ▼ 0.69%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

63117171225279Nov 24, '25May 26, '26Nov 20, '26
  • PBH -13.6%
  • AMLX +75.6%

Head to head

MetricPBHAMLX
Price$49.63$26.02
Change today▲ 0.06%▼ 0.69%
Market cap$2.35B$3.35B
Return, 3 months-4.6%-31.8%
Return, year to date-19.5%+115.4%
Return, 1 year-16.5%+77.4%
P/E (TTM)15.3–
P/B1.24.4
P/E percentile vs own 5y39th3rd
Dividend yield––
Revenue growth (YoY, latest qtr)+22.7%–
Net profit growth (YoY)-40.1%-32.3%
Gross margin52.5%–
Operating margin25.0%–
Net margin13.3%–
Return on equity8.2%-30.1%
Analyst target vs. price+41.0%+77.7%
Analyst buy share100%100%
RSI (14)5639
30-day volatility67.1%58.0%
Max drawdown, 1 year-38.8%-34.4%
Trend readLeaning bullishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AMLX is the largest of the group by market value.
  • AMLX has returned the most over the past year.
  • AMLX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top